Q4 2016 Holdings
Filed 2017-02-13 | 143 holdings | $260.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $152.4M | 537,350 | 58.6% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $47.4M | 572,645 | 18.2% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $9.7M | 127,600 | 3.7% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $9.1M | 243,995 | 3.5% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $9.1M | 639,370 | 3.5% |
| CytomX Therapeutics, Inc.(CTMX) | Common | 23284F105 | $8.3M | 756,090 | 3.2% |
| Cellectis S.A.(CLLS) | Sponsored ADR | 15117K103 | $5.3M | 310,250 | 2.0% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $3.5M | 116,707 | 1.4% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $3.2M | 111,800 | 1.2% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $2.5M | 90,000 | 1.0% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $2.3M | 566,368 | 0.9% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $2.1M | 64,900 | 0.8% |
| Allscripts Healthcare Solutions, Inc.(MDRX) | Common | 01988P108 | $1.8M | 173,600 | 0.7% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $1.1M | 203,935 | 0.4% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $181.2K | 2,530,131 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $163.2K | 1,409,889 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $97.4K | 795,905 | 0.0% |
| Allergan plc | Common | G0177J108 | $91.2K | 434,086 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $88.3K | 880,461 | 0.0% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $76.1K | 1,033,503 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $70.5K | 1,198,349 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $68.9K | 187,666 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $60.8K | 1,583,700 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $51.1K | 443,212 | 0.0% |
| Amgen Inc.(AMGN) | Common | 031162100 | $47.0K | 321,640 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $44.4K | 623,030 | 0.0% |
| Mylan N.V. | Shares | N59465109 | $43.3K | 1,135,552 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $39.4K | 231,413 | 0.0% |
| UnitedHealth Group Inc.(UNH) | Common | 91324P102 | $39.4K | 245,920 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $37.2K | 1,146,689 | 0.0% |
| Eli Lilly & Company(LLY) | Common | 532457108 | $36.3K | 493,100 | 0.0% |
| Jazz Pharmaceuticals plc(JAZZ) | Shares | G50871105 | $36.1K | 331,411 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $33.6K | 164,800 | 0.0% |
| CVS Health Corporation(CVS) | Common | 126650100 | $32.5K | 411,891 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $31.6K | 246,560 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | Sponsored ADR | 881624209 | $28.6K | 788,958 | 0.0% |
| The Medicines Company | Common | 584688105 | $26.2K | 771,638 | 0.0% |
| AmerisourceBergen Corporation(COR) | Common | 03073E105 | $25.9K | 330,687 | 0.0% |
| Centene Corporation(CNC) | Common | 15135B101 | $22.6K | 400,000 | 0.0% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $21.8K | 402,541 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $19.9K | 141,120 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $18.1K | 248,800 | 0.0% |
| Universal Health Services, Inc.(UHS) | Class B | 913903100 | $15.6K | 146,780 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $15.5K | 132,352 | 0.0% |
| iShares Nasdaq Biotechnology ETF(IBB) | ETF | 464287556 | $15.3K | 57,670 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $15.2K | 391,869 | 0.0% |
| Endo International plc | Shares | G30401106 | $15.1K | 914,548 | 0.0% |
| Omega Healthcare Investors, Inc.(OHI) | Common | 681936100 | $14.3K | 458,616 | 0.0% |
| HCA Holdings, Inc.(HCA) | Common | 40412C101 | $14.1K | 190,232 | 0.0% |
| GlaxoSmithKline plc | Sponsored ADR | 37733W105 | $13.8K | 359,000 | 0.0% |